• Amplia Therapeutics: An oral cancer drug trial with serious results!

  • Sep 26 2024
  • Length: 3 mins
  • Podcast

Amplia Therapeutics: An oral cancer drug trial with serious results!

  • Summary

  • Amplia Therapeutics: An oral cancer drug trial with serious results!

    Listen to ASX-listed Amplia Therapeutics Managing Director Chris Burns talk to Matt Birney on the Bulls N’ Bears Report about Amplia’s remarkable drug that looks to be having an impact on a known cancer growth protein.

    See omnystudio.com/listener for privacy information.

    Show More Show Less
activate_samplebutton_t1

What listeners say about Amplia Therapeutics: An oral cancer drug trial with serious results!

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.